cookies-img
We use third-party cookies to provide support. By continuing to browse this website, you accept our privacy policy.
close-icon
Becton Dickinson And Company
67 own
16 watching
Current Price
$249.5
$0
(0%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Market Capitalization
Market Capitalization
90,977.66M
52-Week High
52-Week High
269.06
52-Week Low
52-Week Low
215.9
Average Volume
Average Volume
0.12M
Dividend Yield
Dividend Yield
0.013623
P/E Ratio
P/E Ratio
37.5288
iconMarket Capitalization90,977.66M
icon52-Week High269.06
icon52-Week Low215.9
iconAverage Volume0.12M
iconDividend Yield0.013623
iconP/E Ratio37.5288
What does the Becton Dickinson And Company do?
Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products worldwide. It operates in two segments, BD Medical and BD Life Sciences. The BD Medical segment offers syringes, pen needles, and IV sets for diabetes; needles, syringes, and intravenous catheters for medication delivery; prefilled IV flush syringes; regional anesthesia needles and trays; sharps disposal containers; closed-system transfer devices; skin antiseptic products; surgical and laproscopic instrumentations; intravenous medication safety and infusion therapy delivery, and automated medication dispensing and supply management systems; and prefillable drug delivery systems. The BD Life Sciences segment provides integrated systems for specimen collection; safety-engineered blood collection, automated blood culturing and tuberculosis culturing, and microorganism identification and drug susceptibility systems; molecular testing systems for infectious diseases and women's health; liquid-based cytology systems for cervical cancer screening; rapid diagnostic assays; microbiology laboratory automation, and plated media products; fluorescence-activated cell sorters and analyzers; monoclonal antibodies and kits for performing cell analysis; reagent systems for life science research; molecular indexing and next-generation sequencing sample preparation for genomics research; clinical oncology, immunological, and transplantation diagnostic/monitoring reagents and analyzers; and cell culture media supplements for biopharmaceutical manufacturing. The company markets its products through independent distribution channels and sales representatives to healthcare institutions, life science researchers, clinical laboratories, pharmaceutical industry, and general public. Becton, Dickinson and Company was founded in 1897 and is headquartered in Franklin Lakes, New Jersey.
Read More
How much money does Becton Dickinson And Company make?
News & Events about Becton Dickinson And Company.
PR Newswire
1month ago
BD Recognized by DiversityInc as a Top U.S. Company for Diversity in 2023 List BD Recognized by DiversityInc as a Top U.S. Company for Diversity in 2023 List PR Newswire FRANKLIN LAKES, N.J., May 3, 2023 FRANKLIN LAKES, N.J., May 3, 2023 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE...
PR Newswire
1month ago
BD Recognized by Forbes as a Best Employer for Diversity in 2023 List BD Recognized by Forbes as a Best Employer for Diversity in 2023 List PR Newswire FRANKLIN LAKES, N.J., April 25, 2023 Accolade Represents Positive Perceptions from Employees and Progress in Advancing ESG Strategy FRANKLIN LAKES...
Zolmax
1month ago
New Mexico Educational Retirement Board cut its holdings in Becton, Dickinson and Company (NYSE:BDX Get Rating) by 6.2% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The firm owned 13,666 shares of the medical instruments suppliers stock after selling 900 ...
Zolmax
1month ago
Sompo Asset Management Co. Ltd. grew its stake in Becton, Dickinson and Company (NYSE:BDX Get Rating) by 10.4% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 2,010 shares of the medical ...
Ticker Report
2 months ago
Destiny Wealth Partners LLC raised its holdings in shares of Becton, Dickinson and Company (NYSE:BDX Get Rating) by 6.9% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 1,270 shares of the medical ...
Frequently Asked Questions
Frequently Asked Questions
What is Becton Dickinson And Company share price today?
plus_minus_icon
Can Indians buy Becton Dickinson And Company shares?
plus_minus_icon
How can I buy Becton Dickinson And Company shares from India?
plus_minus_icon
Can Fractional shares of Becton Dickinson And Company be purchased?
plus_minus_icon
What are the documents required to start investing in Becton Dickinson And Company stocks?
plus_minus_icon
What is today’s traded volume of Becton Dickinson And Company?
plus_minus_icon
What is today’s market capitalisation of Becton Dickinson And Company?
plus_minus_icon
What is the 52-Week High and Low Range of Becton Dickinson And Company?
plus_minus_icon
What percentage is Becton Dickinson And Company down from its 52-Week High?
plus_minus_icon
What percentage is Becton Dickinson And Company up from its 52-Week Low?
plus_minus_icon
Current Price
$249.5
$0
(0%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Related Stocks
Penumbra Inc
Penumbra Inc
$320.40
$0.00 (0.00 %)
Stryker Corporation
Stryker Corporation
$275.61
$0.00 (0.00 %)
Medtronic PLC
Medtronic PLC
$82.93
$0.00 (0.00 %)
Baxter International Inc.
Baxter International Inc.
$42.03
$0.00 (0.00 %)
Sign up and dive into a whole new world of investing.
Join over 370,000 who have signed up and are using Stockal successfully already.
Related Stocks
Penumbra Inc
Penumbra Inc
$320.40
$0.00 (0.00 %)
Stryker Corporation
Stryker Corporation
$275.61
$0.00 (0.00 %)
Medtronic PLC
Medtronic PLC
$82.93
$0.00 (0.00 %)
Baxter International Inc.
Baxter International Inc.
$42.03
$0.00 (0.00 %)
Sign up and dive into a whole new world of investing.
Join over 370,000 who have signed up and are using Stockal successfully already.

              Borderless Investing Inc., (“Borderless Investing”), the owner of the Stockal Platform, is not a broker-dealer nor an investment advisor and through its affiliate stockbroker Stockal Securities Pvt. Ltd., (SEBI INZ000301236), acting as the introducing entity has entered into a clearing agreement with DriveWealth LLC., to offer U.S. equities on the Stockal Platform. The Stockal Platform enables investments in a diverse set of global assets from a single account from anywhere in the world. As such, Borderless Investing makes no warranties or representations, express or implied, on products and services offered through its website/platform. It accepts no liability for any damages or losses, however, caused in connection with the use of related services.

              All investments involve risk and returns will fluctuate, are subject to market volatility and may cause losses. The material on this website/platform is provided solely for informational and educational purposes and shall not in any manner be considered a recommendation or endorsement of any strategy or investment, nor an offer to sell or a solicitation of an offer to buy securities, products or services nor advice. Borderless Investing makes no guarantee as to the currency, accuracy, or quality of information published and/or archived on this website/platform, nor will Borderless Investing accept any responsibility for other organizations, businesses, and private persons that provide information on this website/platform. All information on this website/platform regarding products and services provided by Borderless Investing is subject to change without notice. Reasonable efforts are taken to ensure the accuracy and integrity of all information provided here, but Borderless Investing is not responsible for misprints, out of date information, or errors. Any investment decision and/or strategy that investors make or employ, whether or not such decision or strategy derives from or relies upon material accessed or provided through this website/platform, is undertaken at the investor’s sole discretion and risk. Before making any investment decisions, investors should consult additional sources of information and/or their legal or tax advisor. PLEASE READ THIS FULL DISCLOSURE CAREFULLY BEFORE USING THIS SERVICE. BY USING THE SERVICE OR CLICKING AGREE YOU ARE AGREEING TO BE BOUND BY THESE DISCLOSURES AND ALL TERMS AND CONDITIONS ON THIS WEBSITE/PLATFORM.

              *DriveWealth LLC., a member of the Securities Investor Protection Corporation (SIPC), will serve as the custodian for your securities account. In the event that DriveWealth LLC., fails and is placed in liquidation under the Securities Investor Protection Act, securities in your brokerage account may be protected up to $500,000. For details, please see www.sipc.org.

              All brands and logos used on this website are the property of their respective owners.

              Get Started with as little as $1.00